How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa?

Archives of Ophthalmology

Volumn 128, Issue 4, 2010, Pages 493-495

  Massof, Robert W ^a   Fishman, Gerald A ^b  

^a Lions Vision Center   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DOCOSAHEXAENOIC ACID; PLACEBO; RETINOL; RETINOL PALMITATE; XANTHOPHYLL;

ANALYZER; CLINICAL PRACTICE; CLINICAL TRIAL; DIETARY INTAKE; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; EDITORIAL; ELECTRORETINOGRAPHY; FISH; FOLLOW UP; HUMAN; LEAFY VEGETABLE; LIVER FUNCTION TEST; OUTCOME ASSESSMENT; PREGNANT WOMAN; PRIORITY JOURNAL; RETINA DEGENERATION; RETINITIS PIGMENTOSA; SCORING SYSTEM; VISION TEST; VISUAL IMPAIRMENT; VITAMIN SUPPLEMENTATION;

CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; HUMANS; LUTEIN; RETINITIS PIGMENTOSA; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS; VITAMIN A;

EID: 77950824966     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.46     Document Type: Editorial

References (18)

1. Berson EL, Rosner B, Sandberg MA, et al. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol. 2010;128(4):403-411.
2. Berson EL, Rosner B, Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993; 111(6):761-772.
3. Norton EWD. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa [letter to the editor]. Arch Ophthalmol. 1993;111(11):1460.
4. Marmor MF. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa [reply letter]. Arch Ophthalmol. 1993;111(11):1460- 1461.
5. Berson EL, Rosner B, Sandberg MA, et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol. 2004;122(9):1297-1305. (Pubitemid 39180849)
6. Berson EL, Rosner B, Sandberg MA, et al. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol. 2004;122(9):1306-1314. (Pubitemid 39180850)
7. Berson EL, Sandberg MA, Rosner B, Birch DG, Hanson AH. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol. 1985;99(3): 240-251. (Pubitemid 15143427)
8. Birch DG, Anderson JL, Fish GE. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology. 1999;106(2): 258-268.
9. Berson EL, Rosner B, Weigel-DiFranco C, Dryja TP, Sandberg MA. Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations. Invest Ophthalmol Vis Sci. 2002;43(9):3027-3036. (Pubitemid 34977056)
10. Sandberg MA, Rosner B, Weigel-DiFranco C, Dryja TP, Berson EL. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Invest Ophthalmol Vis Sci. 2007;48(3):1298-1304. (Pubitemid 351261427)
11. Nagy D, Schönfisch B, Zrenner E, Jägle H. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography. Invest Ophthalmol Vis Sci. 2008;49(10):4664-4671.
12. Sandberg MA, Rosner B, Weigel-DiFranco C, McGee TL, Dryja TP, Berson EL. Disease course in patients with autosomal recessive retinitis pigmentosa due to USH2A gene. Invest Ophthalmol Vis Sci. 2008;49(12):5532-5539.
13. Massof RW, Dagnelie G, Benzschawel T, Palmer RW, Finkelstein D. First-order dynamics of visual field loss in retinitis pigmentosa. Clin Vis Sci. 1990;5:1-26. (Pubitemid 20075821)
14. Holopigian K, Greenstein V, Seiple W, Carr R. Rates of change differ among measures of visual function in patients with retinitis pigmentosa. Ophthalmology. 1996; 103(3):398-405. (Pubitemid 26085894)
15. Grover S, Fishman GA, Anderson RJ, Alexander KR, Derlacki DJ. Rate of visual field loss in retinitis pigmentosa. Ophthalmology. 1997;104(3):460-465. (Pubitemid 27120301)
16. Iannaccone A, Kritchevsky SB, Ciccarelli ML, et al. Kinetics of visual field loss in Usher syndrome type II. Invest Ophthalmol Vis Sci. 2004;45(3):784-792. (Pubitemid 38868371)
17. Fishman GA, Bozbeyoglu S, Massof RW, Kimberling W. Natural course of visual field loss in patients with type 2 Usher syndrome. Retina. 2007;27(5):601-608. (Pubitemid 46905152)
18. Cideciyan AV, Swider M, Aleman TS, et al. ABCA4 disease progression and a proposed strategy for gene therapy. Hum Mol Genet. 2009;18(5):931-941.